Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Rolan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Pain Research|March 10, 2021
The Relationship Between Androgens and Days per Month of Period Pain, Pelvic Pain, Headache, and TLR4 Responsiveness of Peripheral Blood Mononuclear Cells in Young Women with DysmenorrhoeaSusan F Evans, Yuen Kwok, Ann Solterbeck, et al.
Clinical Pharmacology in Drug Development|January 3, 2025
Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System DiseasePaul Rolan, Jonathan Seckl, Jack Taylor, et al.
Diabetes Care|July 30, 2002
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjectsBodil Elbrønd, Grethe Jakobsen, Søren Larsen, et al.
British Journal of Clinical Pharmacology|January 17, 2007
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy malesMaria Laura Sargentini-Maier, Paul Rolan, John Connell, et al.
Psychoneuroendocrinology|April 2, 2015
Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trialMarni A Nenke, Clare L Haylock, Wayne Rankin, et al.
Pain|October 14, 2025
Biomarkers to predict, prevent, and treat persistent pain: omicsMark R Hutchinson, Daniel Barratt, Charlotte H Johnston, et al.
British Journal of Clinical Pharmacology|November 27, 2008
Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple dosesPaul Rolan, Jacqueline A Gibbons, Lin He, et al.
Cancer Immunology, Immunotherapy : CII|July 18, 2018
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanomaTessa Gargett, M Nazim Abbas, Paul Rolan, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Pain Research|March 10, 2021
The Relationship Between Androgens and Days per Month of Period Pain, Pelvic Pain, Headache, and TLR4 Responsiveness of Peripheral Blood Mononuclear Cells in Young Women with DysmenorrhoeaSusan F Evans, Yuen Kwok, Ann Solterbeck, et al.
Clinical Pharmacology in Drug Development|January 3, 2025
Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System DiseasePaul Rolan, Jonathan Seckl, Jack Taylor, et al.
Diabetes Care|July 30, 2002
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjectsBodil Elbrønd, Grethe Jakobsen, Søren Larsen, et al.
British Journal of Clinical Pharmacology|January 17, 2007
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy malesMaria Laura Sargentini-Maier, Paul Rolan, John Connell, et al.
Psychoneuroendocrinology|April 2, 2015
Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trialMarni A Nenke, Clare L Haylock, Wayne Rankin, et al.
Pain|October 14, 2025
Biomarkers to predict, prevent, and treat persistent pain: omicsMark R Hutchinson, Daniel Barratt, Charlotte H Johnston, et al.
British Journal of Clinical Pharmacology|November 27, 2008
Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple dosesPaul Rolan, Jacqueline A Gibbons, Lin He, et al.
Cancer Immunology, Immunotherapy : CII|July 18, 2018
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanomaTessa Gargett, M Nazim Abbas, Paul Rolan, et al.
Pageof 4